PlumX Metrics
Embed PlumX Metrics

EUCAST technical note on posaconazole *

Clinical Microbiology and Infection, ISSN: 1198-743X, Vol: 17, Issue: 11, Page: E16-E17
2011
  • 18
    Citations
  • 0
    Usage
  • 22
    Captures
  • 0
    Mentions
  • 0
    Social Media
Metric Options:   Counts1 Year3 Year

Metrics Details

  • Citations
    18
    • Citation Indexes
      17
    • Clinical Citations
      1
      • PubMed Guidelines
        1
  • Captures
    22

Article Description

The European Committee on Antimicrobial Susceptibility Testing-Subcommittee on Antifungal Susceptibility Testing (EUCAST-AFST) has determined breakpoints for posaconazole for Candida spp. This Technical Note is based on the EUCAST posaconazole rationale document (available on the EUCAST website: http://www.eucast.org ). Species-specific breakpoints for C. albicans, C. parapsilosis and C. tropicalis are S: MIC ≤0.06 mg/L, R: MIC >0.06 mg/L. There are insufficient data to set breakpoints for C. glabrata and C. krusei as well as non-species-related breakpoints. The breakpoints are based upon pharmacokinetic data, epidemiological cut-off values and clinical experience. Breakpoints will be reviewed regularly.

Bibliographic Details

Arendrup, M C; Cuenca-Estrella, M; Donnelly, J P; Hope, W; Lass-Flörl, C; Rodriguez-Tudela, J-L; European committee on antimicrobial susceptibility testing - subcommittee on antifungal susceptibility testing (EUCAST-AFST)

Elsevier BV

Medicine

Provide Feedback

Have ideas for a new metric? Would you like to see something else here?Let us know